Los Angeles, California
Cancer clinical trials in Los Angeles, CA
384 cancer studies are recruiting participants at sites in Los Angeles as of November 16, 2026, according to ClinicalTrials.gov. Oncology Research Hub can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Los Angeles at a glance
- 384 studies are recruiting at a site in Los Angeles.
- By phase: Early Phase 1 (5), Phase 1 (63), Phase 1/2 (87), Phase 2 (80), Phase 2/3 (10), Phase 3 (86), Phase 4 (2), No phase (25), Observational (26). Studies of devices and behavioral approaches have no phase.
- By sponsor: industry (236), university, hospital or other (126), government (22).
- By research area: Breast Cancer (115), Lung Cancer (97), Prostate Cancer (64), Lymphoma (60), Pancreatic Cancer (26), Melanoma (22).
- Most recent update to one of these records: November 16, 2026.
Breast cancer studies recruiting in Los Angeles
Basic details from each study's public record (the 30 most recently updated of 384). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
Reinvigorating TNBC Response to Immunotherapy With Combination Myeloid Inhibition and Radiation
- Phase 2
- Ages 18 and older
- Female participants
- Sponsor
- Stephen Shiao
- Study site
- Cedars-Sinai Medical Center
- Registry record
- NCT05491226 · updated
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Boehringer Ingelheim
- Study sites
- Ellison Medical Institute · University of California Los Angeles · Valkyrie Clinical Trials
- Registry record
- NCT06324357 · updated
ASTRAEA: ReinvigorAting ReSponse To ImmunotheRApy in MEtAstatic TNBC With Combination Myeloid Inhibition and Radiation
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Stephen Shiao
- Study site
- Cedars-Sinai Medical Center
- Registry record
- NCT07015853 · updated
A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Hoffmann-La Roche
- Study site
- Ellison Medical Institute
- Registry record
- NCT05894239 · updated
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Astellas Pharma Global Development, Inc.
- Study site
- START Los Angeles
- Registry record
- NCT07488676 · updated
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- SWOG Cancer Research Network
- Study site
- USC / Norris Comprehensive Cancer Center
- Registry record
- NCT03418961 · updated
Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid Tumors
- Phase 1
- Ages 12 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study sites
- Keck Medicine of USC Koreatown · Los Angeles General Medical Center · USC / Norris Comprehensive Cancer Center
- Registry record
- NCT05372640 · updated
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- Phase 2
- All ages
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study sites
- Cedars-Sinai Medical Center · The Angeles Clinic and Research Institute - West Los Angeles Office
- Registry record
- NCT05564377 · updated
Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in Los Angeles, CA on ClinicalTrials.gov.
Lung cancer studies recruiting in Los Angeles
A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion
- Phase 2/3
- Ages 18 and older
- All sexes
- Sponsor
- Bristol-Myers Squibb
- Study site
- USC/Norris Comprehensive Cancer Center
- Registry record
- NCT07063745 · updated
A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- BioNTech SE
- Study site
- UCLA Hematology Oncology - Main Site
- Registry record
- NCT07111520 · updated
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Non-Small Cell Lung Cancer
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Verastem, Inc.
- Study sites
- Cedars-Sinai Medical Center · START LA · Valkyrie Clinical Trials
- Registry record
- NCT07659782 · updated
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study sites
- Kaiser Permanente Los Angeles Medical Center · Kaiser Permanente West Los Angeles
- Registry record
- NCT04267848 · updated
Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study site
- Cedars-Sinai Medical Center
- Registry record
- NCT04665739 · updated
Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene)
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Boehringer Ingelheim
- Study site
- Valkyrie Clinical Trials
- Registry record
- NCT04886804 · updated
Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in Los Angeles, CA on ClinicalTrials.gov.
Prostate cancer studies recruiting in Los Angeles
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
- Phase 3
- Ages 18 and older
- Male participants
- Sponsor
- ECOG-ACRIN Cancer Research Group
- Study site
- UCLA / Jonsson Comprehensive Cancer Center
- Registry record
- NCT04423211 · updated
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study sites
- Keck Medicine of USC Koreatown · Los Angeles General Medical Center · USC / Norris Comprehensive Cancer Center
- Registry record
- NCT03866382 · updated
Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in Los Angeles, CA on ClinicalTrials.gov.
Melanoma studies recruiting in Los Angeles
Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma
- Phase 3
- Ages 75 and older
- All sexes
- Sponsor
- ECOG-ACRIN Cancer Research Group
- Study sites
- Los Angeles General Medical Center · USC / Norris Comprehensive Cancer Center
- Registry record
- NCT07068074 · updated
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study sites
- Cedars-Sinai Medical Center · Los Angeles General Medical Center · The Angeles Clinic and Research Institute - West Los Angeles Office
- Registry record
- NCT05136196 · updated
Source: ClinicalTrials.gov. Data processed . See every melanoma study recruiting in Los Angeles, CA on ClinicalTrials.gov.
Lymphoma studies recruiting in Los Angeles
A Multicenter Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-Cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymph...
- No phase
- Ages 1 to 25
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study site
- Children's Hospital of Los Angeles
- Registry record
- NCT05621291 · updated
Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Hoffmann-La Roche
- Study site
- Valkyrie Clinical Trials
- Registry record
- NCT06806033 · updated
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Nurix Therapeutics, Inc.
- Study site
- Cedars-Sinai Medical Center
- Registry record
- NCT07221500 · updated
A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)
- Phase 1
- Ages 0 to 18
- All sexes
- Sponsor
- Autolus Limited
- Study site
- Children's Hospital Los Angeles
- Registry record
- NCT06173518 · updated
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Study site
- Cedars-Sinai Medical Center ( Site 0115)
- Registry record
- NCT06717347 · updated
A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Study site
- Cedar Sinai Cancer Center ( Site 0119)
- Registry record
- NCT07519772 · updated
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study sites
- Kaiser Permanente Los Angeles Medical Center · Kaiser Permanente West Los Angeles
- Registry record
- NCT04269902 · updated
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
- Phase 2
- Ages 1 to 30
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study sites
- Cedars-Sinai Medical Center · Children's Hospital Los Angeles · Mattel Children's Hospital UCLA
- Registry record
- NCT04546399 · updated
Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in Los Angeles, CA on ClinicalTrials.gov.
Pancreatic cancer studies recruiting in Los Angeles
Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
- Phase 2
- Ages 12 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Study site
- Cedars-Sinai Medical Center ( Site 0110)
- Registry record
- NCT04924075 · updated
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Incyte Corporation
- Study sites
- Investigative Site US027 · Investigative Site US036 · Investigative Site US048
- Registry record
- NCT07522073 · updated
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Verastem, Inc.
- Study sites
- Cedars-Sinai Medical Center · START- Los Angeles · Valkyrie Clinical Trials
- Registry record
- NCT07644559 · updated
Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
- No phase
- Ages 18 to 99
- All sexes
- Sponsor
- Cedars-Sinai Medical Center
- Study site
- Cedars-Sinai Medical Center
- Registry record
- NCT04907643 · updated
Source: ClinicalTrials.gov. Data processed . See every pancreatic cancer study recruiting in Los Angeles, CA on ClinicalTrials.gov.
Ask about studies near Los Angeles
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
More locations in California
All California locations
984 studies recruiting across 150 cities.
Duarte
250 studies recruiting.
San Francisco
214 studies recruiting.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.
Oncology Research Hub does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections